Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

October 2015

New Medical Policy on Treatment of Uterine Fibroids

Harvard Pilgrim has developed a clinical medical policy on the treatment of uterine fibroids. This policy takes effect on November 1, 2015, and was developed to provide greater clarity on the medical necessity of certain treatments.

Harvard Pilgrim covers the treatment of uterine fibroids when it is medically necessary. After a review of the research, Harvard Pilgrim has determined that clinical literature supports not treating asymptomatic fibroids. For symptomatic fibroids, the following treatments are considered medically necessary:

  • Transcatheter uterine artery embolization (UAE)
  • Myomectomy

Harvard Pilgrim considers the following treatments for uterine fibroids experimental and investigational and does not provide coverage for them:

  • Laser ablation
  • Cryoablation
  • Cryomyolysis
  • Image-guided thermal ablation using ultrasonography or magnetic resonance imaging (MRI) or MR-guided focused US (e.g. ExAblate, Acessa System)

For further information, please refer to the Uterine Fibroid Treatments Medical Policy posted on our provider website.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


Harvard Pilgrim Rated 5 Out of 5 by NCQA

Medicare Advantage Reminders: Expansion and Prior Authorization Policies

Harvard Pilgrim Offers Provider Support for ICD-10

Harvard Pilgrim Creates Benevera Health in New Hampshire

New HMO Product, Maine’s ChoiceSM, Offered for 2016

Connecticut Hearing Aid Mandate Expands Coverage

New Hampshire Premium Assistance Program: Medicaid Expansion

Medical Group Name to be Listed in Provider Directory


Reminder: Referral Procedure Change for Massachusetts Providers

New Medical Policy on Treatment of Uterine Fibroids

ADHD Diagnosis and Follow-up Care

Harvard Pilgrim Discontinuing Dispensing of C-II Opioids by Mail


2016 CPT and HCPCS codes


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator